Maze Therapeutics, Inc. (MAZE) stock

MAZENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30

$34.33−1.76 (-4.88%)

Close on Nov 13, 2026Market cap $1.91BP/E –Yield –

Maze Therapeutics statistics

62 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Mar 24, 2027 (estimated, before the open)
Last ex-dividend date: No dividends
Fundamentals through: Sep 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $1.91B; $272.32M
Enterprise Value: $1.56B; $146.23M
PB Ratio: 4.45; 2.00
P/TBV Ratio: 4.45; 2.22

Share statisticsIndustry

Shares Outstanding: 56M; 58M
Shares Change (YoY): 88.4%; 10.8%
Shares Change (QoQ): 1.70%; 0.50%
Float: 46M; 49M
Shares Held by Insiders: 16.9%; 11.7%
Shares Held by Institutions: 105.4%; 56.4%

Short sellingIndustry

Short Interest: 7M; –
Short Interest Change: -11.2%; -0.80%
Short % of Float: 14.5%; 9.01%
Short % of Shares Outstanding: 12.0%; 6.30%
Days to Cover: 8.76; 5.15

Stock price statisticsIndustry

52-Week High: $53.65; –
52-Week Low: $21.95; –
20-Day Moving Average: $32.79; –
50-Day Moving Average: $28.68; –
200-Day Moving Average: $31.37; –
Average True Range (14): $1.86; –
Price Change (1 Week): 0.41%; -1.15%
Price Change (1 Month): 24.9%; -4.87%
Price Change (3 Months): 22.8%; -21.0%
Price Change (6 Months): 34.3%; -20.6%
Price Change (YTD): -17.1%; -23.6%
Price Change (1 Year): 5.44%; -22.4%
Average Volume (10 Days): 651,797; –
Average Volume (20 Days): 702,330; –
Average Volume (90 Days): 614,939; –
Relative Volume: 2.26; 0.70
Relative Strength Index (14): 60.3; 43.4
Volatility (1 Year): 67.1%; 80.1%

Returns on capitalIndustry

Return on Equity (ROE): -37.5%; -49.9%
Return on Assets (ROA): -32.4%; -40.6%
Return on Invested Capital (ROIC): -352.7%; -32.9%
Return on Capital Employed (ROCE): -34.0%; -37.9%

Financial positionIndustry

Current Ratio: 14.14; 3.30
Quick Ratio: 13.77; 2.39
Debt / Equity: 0.09; 0.49

EfficiencyIndustry

Profits Per Employee: -$1.07M; -$689.41K
Employee Count: 141; 74

Income statement (TTM)Industry

Operating Income: -$164.16M; -$21.37M
Net Income: -$151.47M; -$22.35M
EBITDA: -$164.16M; -$17.21M
EPS (Diluted): -$2.65; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $389.66M; $68.68M
Total Debt: $39.12M; $116.91M
Net Cash (Debt): $350.54M; $17.76M
Net Cash Per Share: $6.31; $0.80
Equity (Book Value): $428.55M; $53.89M
Book Value Per Share: $7.71; $1.50
Tangible Book Value: $428.55M; $27.13M
Working Capital: $371.80M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: -$114.74M; -$12.38M
Capital Expenditures: -$522.00K; -$1.00M
Free Cash Flow: -$115.26M; -$18.21M
FCF Per Share: -$2.07; -$0.42

Dividends and yieldsIndustry

Earnings Yield: -7.94%; -21.8%
FCF Yield: -6.04%; -9.44%

Scores and fair valueIndustry

Altman Z-Score: 11.94; 0.23
Piotroski F-Score: 3; 4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	MAZE	S&P 500	Difference
1 month	+28.8%	-3.0%	+31.8 pts
3 months	+24.1%	-2.8%	+26.9 pts
Year to date	-17.1%	+11.5%	−28.6 pts
1 year	+7.8%	+13.5%	−5.6 pts

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

7M MAZE shares were sold short on Oct 30, 2026, down 11.2% from the previous report, or 14.47% of the shares available to trade. At recent volumes it would take 8.8 days to buy them back. Over the last 20 sessions, 57.0% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	6,684,604	-11.2%	763,468	8.8
Oct 15, 2026	7,527,939	+14.7%	745,712	10.1
Sep 30, 2026	6,565,330	+15.6%	1,080,934	6.1
Sep 15, 2026	5,678,289	-4.1%	546,179	10.4
Aug 31, 2026	5,918,321	-1.2%	368,764	16.1
Aug 14, 2026	5,988,933	+5.5%	370,295	16.2
Jul 31, 2026	5,678,545	+2.8%	357,598	15.9
Jul 15, 2026	5,525,278	-0.0%	651,947	8.5
Jun 30, 2026	5,527,117	+36.2%	1,028,368	5.4
Jun 15, 2026	4,057,146	+4.1%	527,440	7.7
May 29, 2026	3,897,022	-1.4%	442,125	8.8
May 15, 2026	3,950,970	-9.2%	533,249	7.4

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?